Expleo Solutions Balance Sheet Health
Financial Health criteria checks 6/6
Expleo Solutions has a total shareholder equity of ₹6.7B and total debt of ₹0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₹8.8B and ₹2.0B respectively. Expleo Solutions's EBIT is ₹1.4B making its interest coverage ratio -35.3. It has cash and short-term investments of ₹2.8B.
Key information
0%
Debt to equity ratio
₹0
Debt
| Interest coverage ratio | -35.3x |
| Cash | ₹2.76b |
| Equity | ₹6.71b |
| Total liabilities | ₹2.05b |
| Total assets | ₹8.76b |
Recent financial health updates
No updates
Recent updates
Expleo Solutions Limited's (NSE:EXPLEOSOL) CEO Compensation Is Looking A Bit Stretched At The Moment
Aug 24
When Should You Buy Expleo Solutions Limited (NSE:EXPLEOSOL)?
Jun 21Investors Could Be Concerned With Expleo Solutions' (NSE:EXPLEOSOL) Returns On Capital
Mar 15The Returns On Capital At Expleo Solutions (NSE:EXPLEOSOL) Don't Inspire Confidence
Sep 15Increases to Expleo Solutions Limited's (NSE:EXPLEOSOL) CEO Compensation Might Cool off for now
Aug 19Calculating The Fair Value Of Expleo Solutions Limited (NSE:EXPLEOSOL)
Jul 14Many Would Be Envious Of Expleo Solutions' (NSE:EXPLEOSOL) Excellent Returns On Capital
May 05A Look At The Fair Value Of Expleo Solutions Limited (NSE:EXPLEOSOL)
Mar 15Expleo Solutions Limited's (NSE:EXPLEOSOL) Stock Been Rising: Are Strong Financials Guiding The Market?
Feb 15
Expleo Solutions (NSE:EXPLEOSOL) Knows How to Allocate Capital
Jan 24Introducing Expleo Solutions (NSE:EXPLEOSOL), A Stock That Climbed 76% In The Last Year
Jan 04A Look At The Intrinsic Value Of Expleo Solutions Limited (NSE:EXPLEOSOL)
Dec 14Is There More To The Story Than Expleo Solutions's (NSE:EXPLEOSOL) Earnings Growth?
Nov 26Financial Position Analysis
Short Term Liabilities: EXPLEOSOL's short term assets (₹7.0B) exceed its short term liabilities (₹1.5B).
Long Term Liabilities: EXPLEOSOL's short term assets (₹7.0B) exceed its long term liabilities (₹590.0M).
Debt to Equity History and Analysis
Debt Level: EXPLEOSOL is debt free.
Reducing Debt: EXPLEOSOL had no debt 5 years ago.
Debt Coverage: EXPLEOSOL has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: EXPLEOSOL has no debt, therefore coverage of interest payments is not a concern.